SCHEMBL8287288

SCHEMBL8287288

NC(=O)C1(Nc2ccc(Cl)cc2)CCN([C@@H]2CCCC[C@H]2O)CC1

nearest known ligand 0.55

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SLC18A3 Q16572 11/20 0.55
SIGMAR1 Q99720 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8288007 0.88 SLC18A3 (0.49) SLC18A3SIGMAR1
SCHEMBL8285369 0.88 SLC18A3 (0.44) SLC18A3SIGMAR1
SCHEMBL8285368 0.88 SLC18A3 (0.51) SLC18A3SIGMAR1
SCHEMBL8287289 0.81 SLC18A3 (0.40) SLC18A3
SCHEMBL5557070 0.74 SLC6A9 (0.48)
SCHEMBL14573345 0.74 SLC6A9 (0.48)
SCHEMBL5557067 0.74 SLC6A9 (0.48)
SCHEMBL8287620 0.74 CA12 (0.42) SLC18A3
SCHEMBL27455915 0.73 CA12 (0.43) SLC18A3SIGMAR1
SCHEMBL27539703 0.73 CA12 (0.43) SLC18A3SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005040166-A1 TRIAZA-SPIROPIPERIDINE DERIVATIVES FOR USE AS GLYT-1 INHIBITORS IN THE TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS F.HOFFMANN-LA ROCHE AG (CH) 2005-05-06 WO disclosed